Skip to main content
. 1998 Jun;72(6):4650–4656. doi: 10.1128/jvi.72.6.4650-4656.1998

TABLE 3.

Inactivation of LCMV with immune mouse seruma

Expt Virus Treatment Log10 PFU
Direct assay PEC yield
1 LCMV-SK NHS 3.7 3.5
MEM 3.8 3.3
GT-def 1 (Ab+) 3.8 3.5
GT-def 2 (Ab+) 3.8 3.6
GT-suf (Ab) 3.7 3.5
LCMV-SK-GT NHS 1.7 <1
MEM 3.0 2.1
GT-def 1 (Ab+) 2.5 2.5
GT-def 2 (Ab+) 2.5 2.7
GT-suf (Ab) 3.3 2.8
2 LCMV-SK NHS 3.9 2.0
ΔNHS 4.0 2.3
MEM 4.2 2.4
GT-def (Ab+) 4.1 2.7
GT-suf (Ab) 4.0 3.2
LCMV-SK-GT NHS 2.3 <1
ΔNHS 3.8 2.3
MEM 3.9 2.6
GT-def (Ab+) 3.1 2.1
GT-suf (Ab) 3.8 2.4
a

LCMV passaged in different cell lines was treated with NHS, heat-inactivated NHS (ΔNHS), MEM, or serum from GT-sufficient 129 WT (GT-suf) or GT-deficient (GT-def) mice. All mice had been previously immunized against sheep erythrocytes, but only the GT-deficient mice developed anti-Gal Ab responses. Samples were either titrated directly on Vero cells or used to infect 129 mouse PEC. Virus released into the PEC culture fluid 1 day postinfection was then titrated for PFU on Vero cells.